XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
shares in Thousands, $ in Thousands
 9 Months Ended
Sep. 27, 2024
Sep. 29, 2023
Cash flows from operating activities:    
Net income $ 1,097 $ 153
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 9,171 9,178
Asset impairment and related charges 12,103 0
Stock-based compensation 19,587 20,724
Foreign currency remeasurement 6,513 (814)
Deferred income taxes, net (2,673) 2,026
Provision for excess and obsolete inventories 3,135 6,514
Other adjustments 435 1,689
Changes in operating assets and liabilities:    
Accounts receivable, net (31,611) (2,558)
Inventories 6,592 14,532
Other assets (3,489) 6,164
Accounts payable 1,787 (20,606)
Deferred revenues 2,062 (9,208)
Other liabilities (11,323) (27,002)
Net cash provided by operating activities 13,386 792
Cash flows from investing activities:    
Purchases of short-term investments 0 (6,305)
Purchases of property and equipment (6,840) (5,749)
Net cash used in investing activities (6,840) (12,054)
Cash flows from financing activities:    
Proceeds from long-term debt 115,000 0
Repayment of convertible debt (115,500) 0
Payments for debt issuance costs (332) 0
Repurchase of common stock (30,047) 0
Proceeds from other borrowings 3,943 3,829
Repayment of other borrowings (4,797) (4,721)
Proceeds from common stock issued to employees 6,628 6,552
Taxes paid related to net share settlement of equity awards (6,877) (8,643)
Net cash used in financing activities (31,982) (2,983)
Effect of exchange rate changes on cash and cash equivalents and restricted cash (332) 281
Net decrease in cash and cash equivalents and restricted cash (25,768) (13,964)
Cash and cash equivalents and restricted cash at beginning of period 84,269 89,586
Cash and cash equivalents and restricted cash at end of period 58,501 75,622
Cash and cash equivalents and restricted cash at end of period    
Cash and cash equivalents 58,174 75,622
Restricted cash 327 0
Total cash, cash equivalents and restricted cash as shown in the condensed consolidated statement of cash flows 58,501 75,622
Supplemental cash flow disclosure:    
Income tax payments, net 12,894 6,376
Interest payments, net 4,363 1,921
Supplemental schedule of non-cash investing activities:    
Capital expenditures incurred but not yet paid $ 709 $ 1,802
Supplemental schedule of non-cash financing activities:    
Shares of common stock issued upon redemption of the 2024 Notes (in shares) 4,578 0